Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
Open Access
- 1 January 2012
- journal article
- review article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2012, 1-10
- https://doi.org/10.1155/2012/638185
Abstract
The association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin’s lymphomas (NHL) has been demonstrated by epidemiological studies, in particular in highly endemic geographical areas such as Italy, Japan, and southern parts of United States. In these countries, together with diffuse large B-cell lymphomas, marginal zone lymphomas are the histotypes most frequently associated with HCV infection; in Italy around 20–30% cases of marginal zone lymphomas are HCV positive. Recently, antiviral treatment with interferon with or without ribavirin has been proved to be effective in the treatment of HCV-positive patients affected by indolent lymphoma, prevalently of marginal zone origin. An increasing number of experiences confirmed the validity of this approach in marginal zone lymphomas and in other indolent NHL subtypes like lymphoplasmacytic lymphoma. Across different studies, overall response rate was approximately 75%. Hematological responses resulted significantly associated with the eradication of the virus. This is the strongest evidence of a causative link between HCV and lymphomas. The aim of this paper is to illustrate the relationship between HCV infection and different subtypes of indolent B-cell lymphomas and to systematically summarize the data from the therapeutic studies that reported the use of antiviral treatment as hematological therapy in patients with HCV-associated indolent lymphomas.Keywords
Funding Information
- American International Recruitment Council
This publication has 80 references indexed in Scilit:
- Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trialThe Lancet Oncology, 2011
- Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALTAnnals of Oncology, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateJournal of Hepatology, 2008
- A multicenter retrospective clinical study of CD5/CD10‐negative chronic B cell leukemiasAmerican Journal of Hematology, 2008
- Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study EPILYMPHGastroenterology, 2006
- Hepatitis C viral infection is not associated with Waldenström's macroglobulinemiaAmerican Journal of Hematology, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Clinical Presentation and Management of Marginal Zone LymphomasHematology, 2005
- Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatmentThe Hematology Journal, 2004
- MALT LymphomasHematology, 2001